- Home
- CHGG vs SAVA Comparison
CHGG vs SAVA Comparison
Compare CHGG & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- SAVA
- Stock Information
- Founded
- CHGG 2005
- SAVA 1998
- Country
- CHGG United States
- SAVA United States
- Employees
- CHGG N/A
- SAVA N/A
- Industry
- CHGG Other Consumer Services
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- CHGG Real Estate
- SAVA Health Care
- Exchange
- CHGG Nasdaq
- SAVA Nasdaq
- Market Cap
- CHGG 60.0M
- SAVA 70.5M
- IPO Year
- CHGG 2013
- SAVA N/A
- Fundamental
- Price
- CHGG $0.68
- SAVA $1.77
- Analyst Decision
- CHGG Sell
- SAVA Buy
- Analyst Count
- CHGG 8
- SAVA 3
- Target Price
- CHGG $2.08
- SAVA $54.50
- AVG Volume (30 Days)
- CHGG 1.6M
- SAVA 822.2K
- Earning Date
- CHGG 05-12-2025
- SAVA 05-08-2025
- Dividend Yield
- CHGG N/A
- SAVA N/A
- EPS Growth
- CHGG N/A
- SAVA N/A
- EPS
- CHGG N/A
- SAVA N/A
- Revenue
- CHGG $617,574,000.00
- SAVA N/A
- Revenue This Year
- CHGG N/A
- SAVA N/A
- Revenue Next Year
- CHGG N/A
- SAVA N/A
- P/E Ratio
- CHGG N/A
- SAVA N/A
- Revenue Growth
- CHGG N/A
- SAVA N/A
- 52 Week Low
- CHGG $0.44
- SAVA $1.15
- 52 Week High
- CHGG $5.03
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- CHGG 50.88
- SAVA 56.59
- Support Level
- CHGG $0.66
- SAVA $1.45
- Resistance Level
- CHGG $0.76
- SAVA $1.67
- Average True Range (ATR)
- CHGG 0.06
- SAVA 0.11
- MACD
- CHGG 0.02
- SAVA 0.05
- Stochastic Oscillator
- CHGG 53.58
- SAVA 81.40
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.